MEREO BIOPHARMA (MREO)
(Delayed Data from NSDQ)
$1.74 USD
-0.03 (-1.69%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.73 -0.01 (-0.57%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Mereo BioPharma Group plc - Sponsored ADR has a market cap of $281.43M, which represents its share price of $1.77 multiplied by its outstanding shares number of 159.00M. As a small-cap company, MREO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MREO 1.74 -0.03(-1.69%)
Will MREO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MREO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MREO
RARE, MREO Fall as Osteogenesis Study Likely to Continue Till Year End
MEREO BIOPHARMA (MREO) Upgraded to Buy: What Does It Mean for the Stock?
MREO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MREO
Fell Below 20 Day Moving Average appears for MREO after 1.69% move
Crossed Above 20 Day Moving Average appears for MREO after 2.31% move
Is MREO signaling selling opportunity? Fell Below 20 Day Moving Average shows up after dropping 1.7%
50 Day Moving Average Resistance appears for MREO after 0.0% move
Fell Below 50 Day Moving Average appears for MREO after 4.86% move